BFAM PARTNERS CAYMAN LTD
Q3 2024 Form 13-F
NORTHPOINT, HONG KONG, HONG KONG
CIK 0001639101
· Institutional investment manager
$44.0K Reported Value Total
Reported value
$44.0K
Quarter over quarter
-22.2%
Holdings
1
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Fee Kapadia
Authorized Signer
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2024 13F record
Q3 2024 13F filing summary
| Period of report | September 30, 2024 |
|---|---|
| Filed | November 13, 2024 |
| Form | 13F-HR |
| Reported value | $44.0K |
| Positions | 1 |
| Change in reported value | +17.5% |
| New positions | 0 |
| Exited positions | 0 |
| Position turnover | 0.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2024 13F
Filed Nov 13, 2024
|
1 | $44.0K |
|
Q2 2024 13F
Filed Aug 13, 2024
|
1 | $37.5K |
|
Q1 2024 13F
Filed May 14, 2024
|
1 | $3.9M |
|
Q4 2023 13F
Filed Feb 12, 2024
|
2 | $21.9M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
2 | $21.4M |
|
Q2 2023 13F
Filed Aug 11, 2023
|
4 | $73.3M |
|
Q1 2023 13F
Filed May 12, 2023
|
4 | $96.7M |
|
Q4 2022 13F
Filed Feb 13, 2023
|
4 | $92.4M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
3 | $155.6M |
|
Q2 2022 13F
Filed Aug 12, 2022
|
6 | $168.6M |
|
Q1 2022 13F
Filed May 12, 2022
|
6 | $193.3M |
|
Q4 2021 13F
Filed Feb 11, 2022
|
5 | $646.6M |
|
Q3 2021 13F
Filed Nov 12, 2021
|
5 | $769.5M |
|
Q2 2021 13F
Filed Aug 11, 2021
|
10 | $824.0M |
|
Q1 2021 13F
Filed May 13, 2021
|
5 | $254.3M |
|
Q4 2020 13F
Filed Feb 10, 2021
|
6 | $1.2B |
|
Q3 2020 13F
Filed Nov 13, 2020
|
9 | $876.0M |
|
Q2 2020 13F
Filed Aug 12, 2020
|
9 | $373.4M |
|
Q1 2020 13F
Filed May 12, 2020
|
4 | $166.0M |
|
Q4 2019 13F
Filed Feb 12, 2020
|
6 | $488.1M |
Top 1 holdings · Q3 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | LSBPW LAKESHORE BIOPHARMA CO LTD | $44.0K | 100.0% |
Values as reported on the Q3 2024 Form 13F. Every position is in the holdings table below.